News from Asia

Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets

Written by The Post

SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc.

4 Fun & Productive Things To Keep You Entertained At Home
Not so long ago, people weren't as connected with their homes as they are now. In a sense, most of the workforce felt as if th…
The Exciting Trend of Knockdown Rebuilds in Melbourne
Are you feeling cramped in your current home or dreaming of a space that better reflects your style? If you’re a homeowner in Me…
The Role of Technology in Shaping the Contemporary Workspace
The concept of workspace in Sydney is a pivotal element in the realm of employment. It transcends the mere physicality of a loca…
Commonwealth income support on the way for SA hotspots
Help is available for South Australians and more help is on the way. The Morrison Government has activated income support …
Pros and Cons of Installing Central A/C in Homes
Summer takes a toll on everyone’s comfort. This is where central A/C comes to the rescue of homeowners in Adelaide. Thanks to …
The Role of Cardboard Display Boxes in Effective Product Marketing
In today’s highly competitive retail environment, capturing consumer attention is more challenging than ever. With so many brand…
Unique Ideas for When You Get Stuck With a Long Layover
No one wants to be stuck with a long layover when all they want is to get to their location safely. A long layover can either …
Australia’s favourite emojis revealed, with surprising impacts on mental health
World Emoji Day 2021 – Australia gives emojis the thumbs up SYDNEY, Australia - 16 July 2021: In celebration of World Emoji D…
Key Factors of Ultrasound Skin Lift Treatments
In our late 20s or early 30s, our skin begins to decrease its natural collagen production, which leads to less volume and fullne…